Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-11-10

Clinical Trial Update: A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent Inhalation Aerosol in COPD Patients. [Phase 4]

View source ↗

Summary

A Phase 4 study comparing tiotropium inhalation capsules to Combivent inhalation aerosol in patients with chronic obstructive pulmonary disease; results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Combivent Inhalation Aerosol (ipratropium bromide/albuterol)
  • tiotropium inhalation capsules (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: COMPLETED | Results posted: 2009-11-10